United Therapeutics
UTHR
#1032
Rank
โ‚ฌ18.78 B
Marketcap
415,36ย โ‚ฌ
Share price
0.65%
Change (1 day)
16.64%
Change (1 year)

Market capitalization of United Therapeutics (UTHR)

Market cap: โ‚ฌ18.78 Billion

As of December 2025 United Therapeutics has a market cap of โ‚ฌ18.78 Billion. This makes United Therapeutics the world's 1032th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of United Therapeutics from 1999 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ18.78 B21.64%
2024โ‚ฌ15.44 B65.21%
2023โ‚ฌ9.34 B-20.89%
2022โ‚ฌ11.81 B37.51%
2021โ‚ฌ8.59 B56.68%
2020โ‚ฌ5.48 B58.94%
2019โ‚ฌ3.45 B-16.84%
2018โ‚ฌ4.14 B-22.13%
2017โ‚ฌ5.32 B-7.88%
2016โ‚ฌ5.78 B-11.76%
2015โ‚ฌ6.55 B30.68%
2014โ‚ฌ5.01 B21.56%
2013โ‚ฌ4.12 B103.65%
2012โ‚ฌ2.02 B-4.55%
2011โ‚ฌ2.12 B-22.41%
2010โ‚ฌ2.73 B37.29%
2009โ‚ฌ1.99 B91.72%
2008โ‚ฌ1.03 B-30.15%
2007โ‚ฌ1.48 B68.15%
2006โ‚ฌ0.88 B-34.96%
2005โ‚ฌ1.36 B82.26%
2004โ‚ฌ0.74 B92.18%
2003โ‚ฌ0.38 B16.21%
2002โ‚ฌ0.33 B40.21%
2001โ‚ฌ0.23 B-25.49%
2000โ‚ฌ0.31 B-56.27%
1999โ‚ฌ0.73 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of United Therapeutics was reported to be:

โ‚ฌ17.88 Billion
by Nasdaq info icon info icon
โ‚ฌ18.78 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Eli Lilly
LLY
โ‚ฌ780.30 B 4,053.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ130.54 B 594.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ27.96 B 48.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
โ‚ฌ125.37 B 567.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ8.15 B-56.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚ฌ6.98 B-62.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ84.11 B 347.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
โ‚ฌ40.60 B 116.16%๐Ÿ‡บ๐Ÿ‡ธ USA